Latest Breaking News On - Nicki vasquez - Page 1 : comparemela.com

Sutro Biopharma, Inc (NASDAQ:STRO) Given Average Rating of Buy by Analysts

Sutro Biopharma, Inc (NASDAQ:STRO) Given Average Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nicki vasquezPiper sandlerSutro biopharmaSutro biopharma incSecurities exchange commissionSectoral asset management incVontobel holding ltdOpaleye management incGet free reportMarketbeat ratingsBiopharma trading downExchange commissionCapital partnersCapital managementSectoral asset managementAsset management

Sutro Biopharma, Inc (NASDAQ:STRO) Receives $12 57 Average Price Target from Brokerages

Sutro Biopharma, Inc (NASDAQ:STRO) Receives $12 57 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nicki vasquezSutro biopharmaPiper sandlerVanguard group incExome asset managementBarclays plcNuveen asset managementVirtu financialSutro biopharma incSecurities exchange commissionGet free reportExchange commissionAsset managementBiopharma trading downGet freeSutro biopharma daily

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18 00

Truist Financial Cuts Sutro Biopharma (NASDAQ:STRO) Price Target to $18 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesSutro biopharmaNicki vasquezPrincipal financial group incAmerican century companies incPrudential financial incManufacturers life insurance companySutro biopharma incAmerican international group incFree reportTruist financialBiopharma stock downCentury companiesFinancial groupInternational groupPrudential financial

Sutro Biopharma (NASDAQ:STRO) Receives Overweight Rating from Piper Sandler

Sutro Biopharma (NASDAQ:STRO) Receives Overweight Rating from Piper Sandler
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sutro biopharmaNicki vasquezPiper sandlerMetlife investment managementSutro biopharma company profileBlackrock incSecurities exchange commissionJpmorgan chase coSwiss national bankHealthcare of ontario pension plan trust fundSutro biopharma incGet free reportExchange commissionNational bankOntario pension plan trust fundLife investment management

Sutro Biopharma (NASDAQ:STRO) PT Lowered to $12 00 at HC Wainwright

Sutro Biopharma (NASDAQ:STRO – Free Report) had its price target trimmed by HC Wainwright from $16.00 to $12.00 in a report published on Tuesday, Benzinga reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Sutro Biopharma’s Q1 2024 earnings at ($0.95) EPS, Q2 2024 earnings at ($0.97) […]

Nicki vasquezSutro biopharmaJpmorgan chase coSwiss national bankHealthcare of ontario pension plan trust fundSutro biopharma incBlackrock incMetlife investment managementFree reportNational bankOntario pension plan trust fundLife investment managementGet free reportSutro biopharma daily